Abstract
Fungi are ubiquitous and nearly 1.5 million fungal species exist in the universe, but only few fungi were known to be pathogenic to humans. The temperature of 37 °C, low redox potential in tissues and immune barrier prevent majority of fungi from invading human hosts. However with the change of host environment due to co-morbidities, several saprophytic fungi get the opportunity to adapt to human tissue. The impact of modern medical interventions and fungi adapting to this environment are reasons why many fungi are now known to cause invasive human disease. Fungal infection in humans varies from superficial colonization to invasive diseases and allergic manifestations; each group associated with unique risk factors. Impact of the global burden of fungal infections is often overlooked and estimates are often extrapolations of limited available data. There is also wide variation in the geographical niches occupied by fungi across the world for reasons largely unknown. Natural disasters also contribute to the upsurge of invasive fungal infections. The severity of infection closely parallels a suppression of immunity. Invasive fungal infections are important causes of morbidity and mortality of hospitalized patients. Diagnosis of these fungal infections is often a challenge due to poor sensitivity, specificity and long turnaround times of conventional diagnostic methods. Availability of advanced, rapid technologies is sparse in the majority of laboratories in developing countries. Several biomarkers and molecular techniques are being studied to reduce these turnaround times. In spite of availability of new antifungals, therapy is often empirical due to rapid progression of disease and non-availability of early diagnosis. There is no ideal antifungal agent. Limited spectrum, drug-interaction, toxicity and cost of antifungals are limiting factors. A brief description of these challenges is presented in this introductory chapter.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Casadevall A (2012) Amoeba provide insight into the origin of virulence in pathogenic fungi. Adv Exp Med Biol 710:1–10
Kenyon C et al (2013) A dimorphic fungus causing disseminated infection in South Africa. N Engl J Med 369(15):1416–1424
Malik R et al (2016) Disseminated Emmonsia pasteuriana infection in India: a case report and a review. Mycoses 59(2):127–132
Whittaker RH (1969) New concepts of kingdoms of organisms. Science 163(3863):150–160
Ruggiero MA et al (2015) A higher level classification of all living organisms. PLoS One 10(4):1–60
De Hoog GS et al (2015) Name changes in medically important fungi and their implications for clinical practice. J Clin Microbiol 53(4):1056–1062
Schmalreck AF et al (2014) Phylogenetic relationships matter: antifungal susceptibility among clinically relevant yeasts. Antimicrob Agents Chemother 58(3):1575–1585
Havlickova B, Czaika VA, Friedrich M (2008) Epidemiological trends in skin mycoses worldwide. Mycoses 51(suppl 4):2–15
Sobel JD (2016) Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 214(1):15–21
Sobel JD (2007) Vulvovaginal candidosis. Lancet 369(9577):1961–1971
Brown GD et al (2012) Hidden killers: human fungal infections. Sci Transl Med 4(165):165rv13
Vallabhaneni S et al (2016) The global burden of fungal diseases. Infect Dis Clin N Am 30(1):1–11
Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20(1):133–163
Trick WE et al (2002) Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 35(5):627–630
Bhansali A et al (2004) Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J 80(949):670–674
Supabandhu J et al (2008) Isolation and identification of the human pathogen Pythium insidiosum from environmental samples collected in Thai agricultural areas. Med Mycol 46(1):41–52
Al-Tawfiq JA, Boukhamseen A (2011) Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei (formerly Ramichloridium mackenziei): case presentation and literature review. J Infect Public Health 4(2):96–102
Nucci M et al (2013) Increased incidence of invasive fusariosis with cutaneous portal of entry, Brazil. Emerg Infect Dis 19(10):1567–1572
Slavin MA (2011) Scedosporiosis. Mycoses 54:26
Fahal AH, Sabaa AH (2010) Mycetoma in children in Sudan. Trans R Soc Trop Med Hyg 104(2):117–121
Pfaller MA et al (2011) Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY antimicrobial surveillance program, 2008-2009. Antimicrob Agents Chemother 55(2):561–566
Chakrabarti A et al (2001) Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in northern India. J Clin Microbiol 39(5):1702–1706
Repetto EC, Giacomazzi CG, Castelli F (2012) Hospital-related outbreaks due to rare fungal pathogens: a review of the literature from 1990 to June 2011. Eur J Clin Microbiol Infect Dis 31(11):2897–2904
Kainer MA et al (2012) Fungal infections associated with contaminated methylprednisolone in Tennessee. N Engl J Med 367(23):2194–2203
Litvintseva AP et al (2014) Whole-genome analysis of Exserohilum rostratum from an outbreak of fungal meningitis and other infections. J Clin Microbiol 52(9):3216–3222
Romani L (2011) Immunity to fungal infections. Nat Rev Immunol 11(4):275–288
Aimanianda V et al (2009) Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 460(7259):1117–1121
Mora-Montes HM et al (2011) Recognition and blocking of innate immunity cells by Candida albicans chitin. Infect Immun 79(5):1961–1970
Oksuz S et al (2007) Phospholipase and proteinase activities in different Candida species isolated from anatomically distinct sites of healthy adults. Jpn J Infect Dis 60(5):280–283
Guarner J, Brandt ME (2011) Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev 24(2):247–280
De Pauw B et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG). Clin Infect Dis 46(12):1813–1821
Leung AN et al (1999) Pulmonary infections after bone marrow transplantation: clinical and radiographic findings. Radiology 210(3):699–710
Thomas CF, Limper AH (2004) Pneumocystis pneumonia. N Engl J Med 350(24):2487–2498
Bruno C et al (2007) Comparison of CT features of Aspergillus and bacterial pneumonia in severely neutropenic patients. J Thorac Imaging 22(2):160–165
Kauffman CA (2005) Candiduria. Clin Infect Dis 41(Suppl 6):S371–S376
Arvanitis M et al (2014) Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev 27(3):490–526
Neely LA et al (2013) T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med 5(182):182ra54
Dou YH et al (2013) The role of procalcitonin in the identification of invasive fungal infection-a systemic review and meta-analysis. Diagn Microbiol Infect Dis 76(4):464–469
Karageorgopoulos DE et al (2011) β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 52(6):750–770
Bernardes-Engemann AR et al (2015) Validation of a serodiagnostic test for sporotrichosis: a follow-up study of patients related to the Rio de Janeiro zoonotic outbreak. Med Mycol 53(1):28–33
Harrison E et al (2010) Aspergillus DNA contamination in blood collection tubes. Diagn Microbiol Infect Dis 67(4):392–394
Loeffler J et al (2015) Analytical comparison of in vitro spiked human serum and plasma for PCR-based detection of Aspergillus fumigatus DNA: a study by the European Aspergillus PCR initiative. J Clin Microbiol 53(9):2838–2845
Scheel CM et al (2014) Development of a loop-mediated isothermal amplification method for detection of Histoplasma capsulatum DNA in clinical samples. J Clin Microbiol 52(2):483–488
Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49(9):3640–3645
Pappas PG et al (2016) Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis 62(4):e1–50
Albataineh MT et al (2016) Update from the laboratory: clinical identification and susceptibility testing of fungi and trends in antifungal resistance. Infect Dis Clin N Am 30(1):13–35
Acknowledgements
The authors would like to thank Dr. Ajay Padmanaban for the illustrations.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Chakrabarti, A., Sethuraman, N. (2017). Introduction to Medical Mycology. In: Mora-Montes, H., Lopes-Bezerra, L. (eds) Current Progress in Medical Mycology. Springer, Cham. https://doi.org/10.1007/978-3-319-64113-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-64113-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-64112-6
Online ISBN: 978-3-319-64113-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)